DYADIC INTERNATIONAL INC Convertible Debt
DYADIC INTERNATIONAL INC (DYAI) had Convertible Debt of $1.00 million as of 2025-09-15, per its 10-K filed 2026-03-25.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ConvertibleDebt · last filed 2026-03-25
- 2025-09-15: Convertible Debt $1.00M.
- 2024-03-08: Convertible Debt $6.00M.
| Period end | Convertible Debt |
|---|---|
| 2025-09-15 | $1.00M 10-K · filed 2026-03-25 |
| 2024-03-08 | $6.00M 10-K · filed 2026-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |